Vivos (RDGL) Debt Ratio (2011 - 2023)

Vivos' (RDGL) quarterly Debt Ratio came in at 0.01 in Q3 2023, down 100.0% quarter-over-quarter from 2562.44 in Q3 2018.

Vivos (RDGL) Debt Ratio (2011 - 2023) Analysis & Trends

Vivos has disclosed Debt Ratio across 9 years of filings, most recently posting 0.01 for Q3 2023.

Debt Ratio for Q3 2023 came in at 0.01, changed N/A year-over-year; the trailing twelve-month figure through Sep 2023 was 0.01 (changed N/A YoY), and the FY2016 annual result was 10.76, down 37.1% from the prior year.
Debt Ratio came in at 0.01 for Q3 2023 at Vivos, down from 2562.44 in the prior quarter.
In the past five years, Debt Ratio ranged from a high of 0.01 in Q3 2023 to a low of 0.01 in Q3 2023.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	0.31
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	0.32
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	0.31
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	0.25
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	0.04
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	0.30
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	0.27
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	0.18
10	Vivos	-	-	-3,105.00	-

Historic Data

Download Data

Date	Value
Sep 30, 2023	0.01
Sep 30, 2018	2,562.44
Jun 30, 2018	641.13
Mar 31, 2018	58.39
Sep 30, 2017	12.99
Jun 30, 2017	1.02
Mar 31, 2017	15.30
Dec 31, 2016	10.76
Sep 30, 2016	4.30
Jun 30, 2016	20.56
Mar 31, 2016	4.20
Dec 31, 2015	17.11
Sep 30, 2015	32.57
Jun 30, 2015	1.89
Mar 31, 2015	115.47
Dec 31, 2014	48.94
Sep 30, 2014	3.31
Jun 30, 2014	6.89
Mar 31, 2014	1.59
Dec 31, 2013	1.73